0 items USD 0.00Search
Your search for "DLBCL" gave back 31 results.
The global market for Diffuse Large B-Cell Lymphoma (DLBCL)Treatment Drugs was valued at US$ million in the year 2024 and is projected to reach a...
颁补迟补濒辞驳:听
MRRPB5
May 2025
Price: USD 2,900.00
The global Diffuse Large B-Cell Lymphoma (DLBCL)Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
The global Diffuse Large B-Cell Lymphoma (DLBCL)Treatment Drugs market size was valued at US$ million in 2023. With growing demand in downstream...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
The global Diffuse Large B-Cell Lymphoma (DLBCL)Treatment Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of...
颁补迟补濒辞驳:听
GIR
February 2024
Price: USD 3,480.00
Baculoviral IAP Repeat Containing Protein 5 - Pipeline Review, H2 2019 Summary Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or...
颁补迟补濒辞驳:听
Global Markets Direct
August 2019
Price: USD 3,500.00
Asia Pacific minimal residual disease (MRD) testing market will grow by 15.5% annually with a total addressable market cap of $4,575.0 million over...
颁补迟补濒辞驳:听
Grace Market Data
May 2022
Price: USD 2,980.00
Europe minimal residual disease (MRD) testing market was valued at $ 265.6 million in 2021 and will grow by 11.8% annually over 2021-2031, driven by...
颁补迟补濒辞驳:听
Grace Market Data
May 2022
Price: USD 2,980.00
North America minimal residual disease (MRD) testing market is projected to grow by 11.1% annually in the forecast period and reach $ 1,056.1 million...
颁补迟补濒辞驳:听
Grace Market Data
May 2022
Price: USD 2,980.00
Global minimal residual disease (MRD) testing market will reach $ 2,858.1 million by 2031, growing by 12.4% annually over 2021-2031, driven by the...
颁补迟补濒辞驳:听
Grace Market Data
May 2022
Price: USD 3,480.00
The global CAR-T Cell Immunotherapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
Highlights The global CAR-T Cell Immunotherapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
The global market for Hematological Malignancy Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 3,950.00
The global Hematological Malignancy Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
April 2024
Price: USD 2,900.00
The global Hematological Malignancy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR...
颁补迟补濒辞驳:听
MRRPB5
March 2024
Price: USD 2,900.00
Highlights The global Hematological Malignancy Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
听
